Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain

被引:0
|
作者
Zhou, Xiaojun [1 ]
Zhao, Jingjing [2 ]
Qiu, Yefeng [3 ]
Jia, Rui [1 ]
机构
[1] China Biotechnol Co LTD, Dept Biosafety, Beijing 100025, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Dept Infect Dis, Beijing 100043, Peoples R China
[3] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China
关键词
SARS-CoV-2; Angiotensin-converting enzyme 2; Receptor binding domain; Surface plasmon resonance; African green monkey; RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; SPIKE; PROTEIN;
D O I
10.1016/j.bsheal.2022.09.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused many deaths and contributed to a tremendous public health concern worldwide since 2020. Angiotensin-converting enzyme 2 (ACE2) binds to the SARS-CoV-2 virus as a receptor. The challenge of different nonhuman primate (NHP) species by SARSCoV-2 virus demonstrated different effects on virus replication and disease pathology. This study characterizes differences between host ACE2 sequences of three NHP species: Macaca mulatta, Macaca fascicularis, and Chlorocebus sabaeus. In addition, the binding affinity between the ACE2 ectodomain and the SARS-CoV-2 S receptor-binding domain (RBD) was analyzed. Variation of ACE2 sequence among NHP species and the binding affinity may account for different susceptibility and responses to SARS-CoV-2 infection. (c) 2022 Chinese Medical Association Publishing House. Published by Elsevier BV. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:293 / 298
页数:6
相关论文
共 50 条
  • [1] Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain
    Zhou Xiaojun
    Zhao Jingjing
    Qiu Yefeng
    Jia Rui
    [J]. 生物安全与健康(英文), 2022, 04 (05)
  • [2] Design of protein-binding peptides with controlled binding affinity: the case of SARS-CoV-2 receptor binding domain and angiotensin-converting enzyme 2 derived peptides
    Parisi, Giacomo
    Piacentini, Roberta
    Incocciati, Alessio
    Bonamore, Alessandra
    Macone, Alberto
    Rupert, Jakob
    Zacco, Elsa
    Miotto, Mattia
    Milanetti, Edoardo
    Tartaglia, Gian Gaetano
    Ruocco, Giancarlo
    Boffi, Alberto
    Di Rienzo, Lorenzo
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 10
  • [3] Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
    Murray, Eleanor
    Tomaszewski, Maciej
    Guzik, Tomasz J.
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (07) : E87 - E89
  • [4] The Recognition Pathway of the SARS-CoV-2 Spike Receptor-Binding Domain to Human Angiotensin-Converting Enzyme 2
    Peng, Can
    Lv, Xinyue
    Zhang, Zhiqiang
    Lin, Jianping
    Li, Dongmei
    [J]. MOLECULES, 2024, 29 (08):
  • [5] SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins
    Matthews, Alicia M.
    Biel, Thomas
    Ortega-Rodriguez, Uriel
    Falkowski, Vincent
    Bush, Xin
    Faison, Talia
    Xie, Hang
    Agarabi, Cyrus
    Rao, V. Ashutosh
    Ju, Tongzhong
    [J]. PLOS ONE, 2022, 17 (12):
  • [6] Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2
    Aiello, Federica
    Balzano, Federica
    Barretta, Gloria Uccello
    D'Acquarica, Ilaria
    Mazzoccanti, Giulia
    Agranat, Israel
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 237
  • [7] Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain
    Lupala, Cecylia Severin
    Kumar, Vikash
    Su, Xiao-Dong
    Wu, Chun
    Liu, Haiguang
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 141
  • [8] Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain
    Lupala, Cecylia Severin
    Kumar, Vikash
    Su, Xiao-dong
    Wu, Chun
    Liu, Haiguang
    [J]. Computers in Biology and Medicine, 2022, 141
  • [9] High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
    Esparza, Thomas J.
    Martin, Negin P.
    Anderson, George P.
    Goldman, Ellen R.
    Brody, David L.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme
    Thomas J. Esparza
    Negin P. Martin
    George P. Anderson
    Ellen R. Goldman
    David L. Brody
    [J]. Scientific Reports, 10